According to Future Market Insights, the insect cell lines market is projected to reach a market value of US$ 1 billion by the end of 2023 and is expected to grow at a CAGR of 11.6% to reach US$ 3 billion in 2033.
Data Points
Key Statistics
Expected Market Value in 2023
US$ 1 billion
Projected Market Value in 2033
US$ 3 billion
Growth Rate (2023 to 2033)
11.6% CAGR
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The Buzz around Insect Cell Lines: Exploring the Growth of a Rapidly Evolving Market
The insect cell line market is growing rapidly due to several factors. Here are some of the noteworthy drivers that are contributing to the growth of this market:
A growing interest in genetically modified organisms (GMOs): There is a growing interest in the use of GMOs for producing biopharmaceuticals, and insect cell lines are often used to produce GMOs. As the market for GMOs grows, so too will the market for insect cell lines.
Growing demand for insect-derived products: Insect-derived products, such as chitin and insect-based food products are becoming increasingly popular due to their environmental and economic benefits. This growing demand for insect-derived products is contributing to the growth of the insect cell lines market.
Rising demand for animal-free products: There is a growing demand for animal-free products, including biopharmaceuticals. Insect cell lines are an animal-free alternative to traditional cell culture methods, making them an attractive option for the production of biopharmaceuticals.
Discovering the Next Frontier: Opportunities in the Insect Cell Lines Industry
The insect cell lines market is an evolving industry, offering new and exciting opportunities for companies in the biotechnology and biopharmaceutical sectors. Here are some of the latest opportunities in the market:
Growing Demand for Cell-Based Therapies: The use of cell-based therapies is growing rapidly, and insect cell lines are being used to produce these therapies. This growing demand is creating an opportunity for companies to develop and produce insect cell lines for use in the production of cell-based therapies.
Development of Novel Therapies: The development of new and novel therapies is a prominent area of focus in the biotechnology and biopharmaceutical sectors, and insect cell lines are being used to produce these therapies. Companies that are able to develop and produce insect cell lines for use in the production of novel therapies are well-positioned to capture a significant share of the market.
The Emergence of New Applications: The insect cell lines market is constantly evolving, and new applications for insect cell lines are being discovered regularly. Companies that are able to identify and take advantage of these new applications are well-positioned to capture a significant share of the market.
Find your sweet spots for generating winning opportunities in this market.
Uncovering the Next Big Thing: Latest Trends in the Insect Cell Lines Industry
The insect cell lines market is currently exhibiting several cutting-edge trends, with advancements and shifts in the industry continually shaping its trajectory as mentioned below:
Focus on Sustainable Production Methods: Companies are increasingly focusing on sustainable production methods, and insect cell lines are being used to support these efforts. Companies that are able to provide insect cell lines for use in sustainable biopharmaceutical production are well-positioned to capture a significant share of the market.
Development of High-Throughput Systems: Companies are developing high-throughput systems for the production of insect cell lines, and this trend is contributing to the growth of the market. Companies that are able to develop and provide high-throughput insect cell line production systems are well-positioned to capture a significant share of the market.
Emergence of New Insect Cell Line Types: New types of insect cell lines are being developed, and these cell lines offer new opportunities for companies in the market. Companies that are able to develop and provide these new insect cell lines are well-positioned to capture a significant share of the market.
Tissue culture is the in-vitro procedure for culturing tissues aseptically using growth medium. Insect cell culture is a special media used for production of vaccines, virus like particles and recombinant proteins. Thomas D.C Grace, in 1962 established the first insect cell culture medium namely Emperor Gum Moth Antherea Eucalipty. There are about more than 500 from 75 different species.
Lepidopteram, Diptern, Orthopteran are some species of insects used for insect cell lines. Insect cell line usually take 18-72 hours doubling time. Insect cell lines has various advantages in vaccine production as it is capable of post translational modifications, high protein expression yield during vaccine production against virus,
Insect cell lines Market: Drivers and Restraints
Rise in prevalence of chronic disease like cancer is a prime factor driving the growth of insect cell lines market. Also, rising awareness regarding advanced therapies using genetic engineering may upsurge the demand for insect cell lines market. The American Cancer Society estimates that in 2020, about 21,750 new cases of ovarian cancer will be diagnosed and 13,940 women will die of ovarian cancer in the United States.
This has led the high focus of pharmaceutical industry to provide utter quality of vaccines for viral related cancers cancer may also responsible for the rapid progress of insect cell lines market. Additionally, the availability of favorable reimbursement scenario in developed economies will also propel the growth of insect cell lines market.
On the other hand, prohibitive cost of insect cell lines and lack of funding may deter the growth of insect cell lines market in under developing economies.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Insect cell lines Market: Overview
Among product type, High Five insect cell lines captures the highest revenue share as the cell line produce higher levels of recombinant proteins used in medicine. Also, High Five insect lines survive in serum free media that helps to make it contamination free.
These cell lies can be produced using E. coli due to its high reproducibility property. Among all application of biopharmaceutical industries will hold the highest share as the increased funding for research and development for vaccine production. Among all end user, pharmaceutical industry will hold the largest share segment in insect cell lines market and is anticipated to grow at a significant rate over the forecast period.
Insect cell lines Market: Regional Overview
North America will show the high revenue for the insect cell lines market, as the prevalence of chronic disease is more in the region and increased funding for vaccine development to pharmaceutical industry. After North America, the Europe region will show the robust growth for the insect cell lines market in the near future, due to availability of better R&D infrastructure European countries.
Latin America region will show the significant demand for the insect cell lines, due to the regional government initiative towards the health in countries like Brazil and Mexico. In Asian countries like China and India, may show the additional demand for the insect cell lines as the people are being aware about treatment using advanced therapies using genetic engineering.
The Middle East and Africa are expected to be least lucrative region for insect cell lines market due to lack of awareness about the women health.
Insect cell lines Market: Key Players
Examples of some of the market participants in Insect cell lines market identified across the value chain include Corning (Cellgro), Thermo Fisher, GE Healthcare Lonza, Hi-Media, Merck Millipore, &CellGenix, Atlanta Biologicals, PromoCell and others.
Product launches is the main strategy followed by the manufacturers for insect cell lines market. On March 2020, Lonza has launched a new insect cell line medium to increase the production of Adeno Associated Virus (AAV) in Spodoptera Fuigiperda (Sf9) insect cells lines.
The research report on insect cell lines market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies.
The research report on Insect cell lines market provides analysis and information according to market segments such as geographies, application, and industry.
The report covers exhaust analysis on Insect cell lines market
Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Report on Insect cell lines market includes regional analysis
North America (USA, Canada)
Latin America (Mexico, Brazil)
Europe (Germany, Italy, France, United Kingdom, Spain, Russia)
East Asia (China, Japan, South Korea)
South Asia (India, ASEAN)
Oceania (Australia, New Zealand)
Middle East and Africa (GCC Countries, South Africa, Northern Africa)
The report on insect cell lines market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Insect cell lines Market: Segmentation
The global insect cell lines market is classified on the basis of product type, application, and end user
Based on product type, insect cell lines market is segmented into the following:
Sf9
Sf21
High Five
Based on application, insect cell lines market is segmented into the following:
Biopharmaceutical Manufacturing
Tissue Culture & Engineering
Gene Therapy
Cytogenetic
Based on end user, insect cell lines market is segmented into the following:
